These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 3551617)
1. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Flach AJ; Dolan BJ; Irvine AR Am J Ophthalmol; 1987 Apr; 103(4):479-86. PubMed ID: 3551617 [TBL] [Abstract][Full Text] [Related]
2. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Flach AJ; Jampol LM; Weinberg D; Kraff MC; Yannuzzi LA; Campo RV; Neumann AC; Cupples HP; Lefler WH; Pulido JS Am J Ophthalmol; 1991 Nov; 112(5):514-9. PubMed ID: 1951587 [TBL] [Abstract][Full Text] [Related]
3. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Heier JS; Topping TM; Baumann W; Dirks MS; Chern S Ophthalmology; 2000 Nov; 107(11):2034-8;discussion 2039. PubMed ID: 11054327 [TBL] [Abstract][Full Text] [Related]
4. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Flach AJ; Lavelle CJ; Olander KW; Retzlaff JA; Sorenson LW Ophthalmology; 1988 Sep; 95(9):1279-84. PubMed ID: 3062540 [TBL] [Abstract][Full Text] [Related]
5. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Flach AJ; Stegman RC; Graham J; Kruger LP Ophthalmology; 1990 Oct; 97(10):1253-8. PubMed ID: 2243674 [TBL] [Abstract][Full Text] [Related]
6. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Weisz JM; Bressler NM; Bressler SB; Schachat AP Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530 [TBL] [Abstract][Full Text] [Related]
7. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Gillies GW; Kenny GN; Bullingham RE; McArdle CS Anaesthesia; 1987 Jul; 42(7):727-31. PubMed ID: 3307518 [TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study. Flach AJ; Graham J; Kruger LP; Stegman RC; Tanenbaum L Arch Ophthalmol; 1988 Mar; 106(3):344-7. PubMed ID: 3345153 [TBL] [Abstract][Full Text] [Related]
9. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. Simone JN; Pendelton RA; Jenkins JE J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648 [TBL] [Abstract][Full Text] [Related]
11. A multiple-dose comparison of ketorolac tromethamine with diflunisal and placebo in postmeniscectomy pain. Honig WJ; Van Ochten J J Clin Pharmacol; 1986; 26(8):700-5. PubMed ID: 3540032 [TBL] [Abstract][Full Text] [Related]
12. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone. Flach AJ; Jaffe NS; Akers WA Ann Ophthalmol; 1989 Nov; 21(11):407-11. PubMed ID: 2619149 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy. Brint SF; Cheetham JK; DeGryse R; Abel ML; Thompson VM; Rosenthal A J Cataract Refract Surg; 1999 Jan; 25(1):41-9. PubMed ID: 9888075 [TBL] [Abstract][Full Text] [Related]
14. Cystoid macular edema due to cytomegalovirus retinitis in a patient with acquired immune deficiency syndrome. Weinberg DV; Moorthy RS Retina; 1996; 16(4):343-4. PubMed ID: 8865398 [No Abstract] [Full Text] [Related]
15. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004 [TBL] [Abstract][Full Text] [Related]
16. Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone. Singal N; Hopkins J Can J Ophthalmol; 2004 Apr; 39(3):245-50. PubMed ID: 15180141 [TBL] [Abstract][Full Text] [Related]
17. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Flach AJ; Kraff MC; Sanders DR; Tanenbaum L Arch Ophthalmol; 1988 Apr; 106(4):480-3. PubMed ID: 3355415 [TBL] [Abstract][Full Text] [Related]
18. Analgesic efficacy and safety of nonpreserved ketorolac tromethamine ophthalmic solution following radial keratotomy. Ketorolac Radial Keratotomy Study Group. Yee RW Am J Ophthalmol; 1998 Apr; 125(4):472-80. PubMed ID: 9559732 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Stewart R; Grosserode R; Cheetham JK; Rosenthal A Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737 [TBL] [Abstract][Full Text] [Related]
20. A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Corneal Abrasion Patching Study Group. Kaiser PK; Pineda R Ophthalmology; 1997 Aug; 104(8):1353-9. PubMed ID: 9261326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]